| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/06/1994 | CA2138970A1 Membrane-associated immunogens of mycobacteria |
| 01/06/1994 | CA2138948A1 Molecular cloning of the genes responsible for collagenase production from clostridium histolyticum |
| 01/06/1994 | CA2138807A1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/06/1994 | CA2138770A1 Heteroatomic oligonucleoside linkages |
| 01/06/1994 | CA2138516A1 Gene for vitamin d hydroxylase |
| 01/06/1994 | CA2138414A1 Protein based delivery system |
| 01/06/1994 | CA2137346A1 Dna sequences encoding oligosaccharide transporter |
| 01/06/1994 | CA2136986A1 Gene for ataxia-telangiectasia complementation group d (atdc) |
| 01/06/1994 | CA2136981A1 Dna encoding precursor interleukin 1.beta. converting enzyme |
| 01/06/1994 | CA2136828A1 Dna sequences and plasmids for the preparation of plants with changed sucrose concentration |
| 01/06/1994 | CA2136765A1 Methods for using cks fusion proteins |
| 01/06/1994 | CA2136432A1 Deproteinization with azlactone-functional supports |
| 01/06/1994 | CA2135313A1 Methods for producing transgenic non-human animals harboring a yeast artificial chromosome |
| 01/06/1994 | CA2120745A1 A combination of anti-erbb-2 monoclonal antibodies and method of using |
| 01/06/1994 | CA2116109A1 Multimeric forms of human rhinovirus receptor protein |
| 01/05/1994 | EP0577458A1 Nucleotide and Peptide sequences of the FIV isolate WO and their uses in diagnostic and prevention of the feline immunodeficiency virus infection |
| 01/05/1994 | EP0577257A1 Alpha-amylase from hyperthermophilic archaebacterium |
| 01/05/1994 | EP0577254A1 Method for cloning and producing the nael restriction endonuclease and methylase |
| 01/05/1994 | EP0577252A1 Transgenic tomato plants with altered polygalacturonase isoforms |
| 01/05/1994 | EP0577243A2 Recombinant human HIV-neutralizing monoclonal antibodies for prevention and treatment of HIV infection |
| 01/05/1994 | EP0577144A1 Detection of a unique Chlamydia strain associated with acute respiratory disease |
| 01/05/1994 | EP0577028A2 Anti-DCC gene product specific monoclonal antibody |
| 01/05/1994 | EP0576953A2 Production of human cathepsin and its use |
| 01/05/1994 | EP0576899A1 A gene coding a protein having a lipase activity and a process for producing the same |
| 01/05/1994 | EP0576862A2 DNA for immortalisation of human or animal cells |
| 01/05/1994 | EP0576842A2 Method and means for detecting listeria |
| 01/05/1994 | EP0576792A2 Plasmids and process for producing recombinant desulphatohirudin HV-1 peptide |
| 01/05/1994 | EP0576674A1 Novel plasmid |
| 01/05/1994 | EP0576623A1 Binding domains in notch and delta proteins |
| 01/05/1994 | EP0576621A1 Ethanol production by recombinant hosts |
| 01/05/1994 | EP0576609A1 Receptors for bombesin-like peptides |
| 01/05/1994 | EP0576606A1 Residual protease-iii |
| 01/05/1994 | EP0576592A1 Oligosaccharide enzyme substrates and inhibitors: methods and compositions |
| 01/05/1994 | EP0576590A1 Response element compositions and assays employing same |
| 01/05/1994 | EP0576483A1 Biocidal proteins |
| 01/05/1994 | EP0576471A1 Recombinant virus vectors encoding human papillomavirus proteins |
| 01/05/1994 | EP0576439A1 Monoclonal antibody against lps core |
| 01/05/1994 | DE4222289C1 Verfahren und Mittel zur Instabilisierung von viralen Quasi-Spezies-Verteilungen unter Vermeidung von Resistenzphänomenen Method and means for instabilization of viral quasi-species distributions while avoiding phenomena of resistance |
| 01/05/1994 | DE4221840A1 Bivalente Lebendvakazine gegen bakterielle Darmpathogene, Herstellungsverfahren sowie Plasmide und Stämme als Ausgangsmaterial Bivalent Lebendvakazine against bacterial enteric pathogens, production processes, and plasmids and strains as starting material |
| 01/05/1994 | DE4220981A1 Transfer of large DNA sequences by conjugation - using donor contg. chromosomally integrated self-transferable or mobilisable hybrid plasmid |
| 01/05/1994 | DE4220759A1 DNA-Sequenzen für Oligosaccharid-Transporter, Plasmide, Bakterien und Pflanzen enthaltend einen Transporter sowie Verfahren zur Herstellung und Transformation von Hefestämmen zur Identifikation des Transporteers DNA sequences for oligosaccharide transporter, plasmids, bacteria and plants containing a van and processes for the production and transformation of yeast strains to identify the Transporteers |
| 01/05/1994 | DE4220758A1 DNA-Sequenz und Plasmide zur Herstellung von Pflanzen mit veränderter Saccharose-Konzentration DNA sequence and plasmids for the production of plants with altered sucrose concentration |
| 01/05/1994 | CN1080188A Prevention of retinal injury and degeneration by specific factors |
| 01/04/1994 | US5276494 High-speed printing device having a particle trap arranged in the paper channel |
| 01/04/1994 | US5276269 Lectin cDNA and transgenic plants derived therefrom |
| 01/04/1994 | US5276268 Phosphinothricin-resistance gene, and its use |
| 01/04/1994 | US5276019 Inhibitors for replication of retroviruses and for the expression of oncogene products |
| 01/04/1994 | US5276013 Conjugates of biologically stable polyfunctional molecules and polynucleotides for treating systemic lupus erythematosus |
| 01/04/1994 | US5275947 Non-A, non-B hepatitis virus antigen peptide |
| 01/04/1994 | US5275946 Thrombolytic agents with modified kringle domains |
| 01/04/1994 | US5275942 Mammalian cell-based DNA libraries |
| 01/04/1994 | US5275934 Method of detecting viral infection in vaccinated animals |
| 01/04/1994 | US5275201 Manifold valve assembly with removable valve seat |
| 01/04/1994 | CA2099531A1 Monoclonal antibodies to hiv-1 gp120, cell lines producing them, preparations for passive immunotherapy, vaccines containing corresponding epitope structures and process for preparing these antibodies |
| 01/04/1994 | CA1325781C Methods of regulating protein glycosylation |
| 01/03/1994 | CA2567357A1 Anther-specific cdna sequences, genomic dna sequences and recombinant dna sequences |
| 12/29/1993 | EP0576152A1 Protease and related DNA compounds |
| 12/29/1993 | EP0576092A1 Recombinant Feline herpesvirus vaccine |
| 12/29/1993 | EP0576050A1 Isolation and characterisation of the sfp gene of Bacillus subtilis |
| 12/29/1993 | EP0576049A1 A method of using eukaryotic expression vectors comprising the BK virus enhancer |
| 12/29/1993 | EP0575845A2 Method for HLA-DP typing |
| 12/29/1993 | EP0575559A1 TGF-$g(b)1/$g(b)2: A NOVEL CHIMERIC TRANSFORMING GROWTH FACTOR-BETA |
| 12/29/1993 | EP0575555A1 Protein-induced morphogenesis |
| 12/29/1993 | EP0575553A1 Recombinant hybrid porin epitopes |
| 12/29/1993 | EP0575546A1 Prad1 cyclin and its cdna |
| 12/29/1993 | EP0575544A1 Malaria recombinant poxvirus vaccine |
| 12/29/1993 | EP0575539A1 Means for in-vitro diagnosis of constituents of cytoplasmic granules and biological applications |
| 12/29/1993 | EP0575537A1 Soluble cd28 proteins and methods of treatment therewith |
| 12/29/1993 | EP0575528A1 Response element compositions and assays employing same |
| 12/29/1993 | EP0575518A1 Methods and compositions for the selective inhibition of gene expression |
| 12/29/1993 | EP0575491A1 Genetically engineered vaccine strain |
| 12/29/1993 | EP0575485A1 Process for the development of binding mini-proteins |
| 12/29/1993 | EP0575464A1 Modified factor vii |
| 12/29/1993 | EP0575462A1 A process for producing chymosin. |
| 12/29/1993 | EP0575410A1 The biological selection of useful molecules |
| 12/29/1993 | EP0575407A1 Humanised antibodies having modified allotypic determinants |
| 12/29/1993 | EP0575387A1 Extraction system. |
| 12/29/1993 | EP0575357A1 Human follicle stimulating hormone receptor |
| 12/29/1993 | EP0575350A1 Method for culturing and transforming human stem cell-containing compositions |
| 12/29/1993 | EP0575339A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 12/29/1993 | EP0575338A1 Multisite integration cassette for the genome of a yeast |
| 12/29/1993 | EP0575319A1 Cloning and expression of renilla luciferase |
| 12/29/1993 | EP0559729A4 Control of plant cell proliferation and growth |
| 12/29/1993 | EP0546091A4 Homologous recombination in mammalian cells |
| 12/29/1993 | EP0539573A4 Genomic modifications with homologous dna targeting |
| 12/29/1993 | EP0538398A4 Tissue-derived tumor growth inhibitors, methods for preparation and uses thereof |
| 12/29/1993 | EP0455682B1 Polypeptides having a human beta-adrenergic receptor activity, and playing a role in lipolytic response, nucleic acids coding for these polypeptides and use of said polypeptides for screening substances which act on these polypeptides |
| 12/29/1993 | EP0408675A4 Detection of human tumor progression and drug resistance |
| 12/29/1993 | EP0375743B1 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
| 12/29/1993 | EP0365597B1 Improved processes for the treatment of vascular disease |
| 12/29/1993 | CN1079992A Neurotrophic factors having altered receptor binding specificities |
| 12/28/1993 | US5274087 cDNA coding for carcinoembryonic antigen (CEA) |
| 12/28/1993 | US5274077 Protein or fragment thereof having a hormone or DNA binding domain of the recptor |
| 12/28/1993 | US5273966 Having two mannose residues attached to the threonine (29) amino acid |
| 12/28/1993 | US5273962 Human urinary thrombomodulin with a modified glycosaminoglycan (GAG) binding site |
| 12/28/1993 | US5273902 Genetically modified vibrio |
| 12/28/1993 | US5273901 Genetically engineered coccidiosis sporozoite 21.5 Kb antigen, ac-6b |
| 12/28/1993 | US5273894 Phosphinothricin-resistance gene, and its use |
| 12/28/1993 | US5273889 Gamma-iterferon-leukotoxin gene fusions and uses thereof |
| 12/28/1993 | US5273884 Polypetides, antigens or vaccines protective against babesiosis |